Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Renal Cell × etoposide phosphate × 90 days × Clear all

Sponsor

Conditions

Neuroblastoma 4 Sarcoma, Ewing 2 Rhabdoid Tumor 2 Medulloblastoma 2 Lymphoma 2 Leukemia, Myeloid, Acute 2 Ganglioneuroblastoma 2 Ependymoma 2 Brain Neoplasms 2 Sarcoma 1 Rhabdomyosarcoma 1 Recurrence 1 Pinealoma 1 Osteosarcoma 1 Nervous System Neoplasms 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Myelodysplastic Syndromes 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Immunoblastic Lymphadenopathy 1 Hodgkin Disease 1 Histiocytosis, Langerhans-Cell 1 Glioma 1 Enteropathy-Associated T-Cell Lymphoma 1 Diffuse Intrinsic Pontine Glioma 1

Interventions

pembrolizumab 27 Nivolumab 26 cabozantinib 25 Magnetic Resonance Spectroscopy 19 Specimen Handling 16 Ipilimumab 16 lenvatinib 10 belzutifan 7 atezolizumab 7 Biopsy 7 Axitinib 7 Sunitinib 6 Everolimus 6 CTLA-4 Antigen 6 avelumab 5 aldesleukin 5 Radiosurgery 5 Immunoglobulin G 5 Bevacizumab 5 pazopanib 4 fludarabine 4 Disulfides 4 Cyclophosphamide 4 zimberelimab 3 palbociclib 3 cemiplimab 3 Radiotherapy 3 Nephrectomy 3 IFL protocol 3 toripalimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡